Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Candidemia D058387 2 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Xerostomia D014987 6 associated lipids
Vaginitis D014627 6 associated lipids
Urethritis D014526 9 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Peritonitis D010538 38 associated lipids
Otitis Externa D010032 8 associated lipids
Mycoses D009181 18 associated lipids
Leishmaniasis D007896 19 associated lipids
Influenza, Human D007251 11 associated lipids
Hypertension D006973 115 associated lipids
HIV Seropositivity D006679 15 associated lipids
Hemolysis D006461 131 associated lipids
Gonorrhea D006069 7 associated lipids
Dermatomycoses D003881 17 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Wittekamp BH et al. Nystatin versus amphotericin B to prevent and eradicate Candida colonization during selective digestive tract decontamination in critically ill patients. 2015 Intensive Care Med pmid:26459880
Sasek V Consequences of Misnomer or Mistakes in Identification of Fungal Species. 2015 Int J Med Mushrooms pmid:26853957
Guerra CM et al. Duration of prophylaxis against fungal infection in kidney transplant recipients. 2015 Prog Transplant pmid:26645924
Austin N et al. Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. 2015 Cochrane Database Syst Rev pmid:26497202
Tamura M et al. Involvement of an intracellular vesicular transport process in naked-sgRNA-mediated TRUE gene silencing. 2015 Mol Med Rep pmid:26238202
Semis R et al. Evaluation of antifungal combinations of nystatin-intralipid against Aspergillus terreus using checkerboard and disk diffusion methods. 2015 J Mycol Med pmid:25639922
Martín MJ et al. Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery. 2015 Carbohydr Polym pmid:25498619
Fan S et al. Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis. 2015 Mycopathologia pmid:25416649
Zhu Y et al. Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis. 2015 Mycopathologia pmid:25322705
Oncel MY et al. Comparison of Lactobacillus reuteri and nystatin prophylaxis on Candida colonization and infection in very low birth weight infants. 2015 J. Matern. Fetal. Neonatal. Med. pmid:25245226
Rizk NN et al. Use of topical lidocaine, diphenhydramine hydrochloride, nystatin, and gabapentin swish in treatment for post-radiation neuropathy and oral mucositis. 2014 May-Jun Pain Physician pmid:24850125
Hemmateenejad B et al. Photodegradation study of nystatin by UV-Vis spectrophotometry and chemometrics modeling. 2014 Jul-Aug J AOAC Int pmid:25145159
Ren J et al. Enhancement of nystatin production by redirecting precursor fluxes after disruption of the tetramycin gene from Streptomyces ahygroscopicus. 2014 Jul-Aug Microbiol. Res. pmid:24231162
Gøtzsche PC and Johansen HK Nystatin prophylaxis and treatment in severely immunodepressed patients. 2014 Cochrane Database Syst Rev pmid:25188770
Johansen HK and Gøtzsche PC Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients. 2014 Cochrane Database Syst Rev pmid:25188769
Anil S et al. Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals. 2014 Mycopathologia pmid:25142726
Chulkov EG et al. Direct visualization of solid ordered domains induced by polyene antibiotics in giant unilamellar vesicles. 2014 Chem. Phys. Lipids pmid:25068758
Lewis M The role of antifungal and antiviral agents in primary dental care. 2014 Prim Dent J pmid:25668378
Ellepola AN et al. The postantifungal effect of nystatin and its impact on adhesion attributes of oral Candida dubliniensis isolates. 2014 Mycoses pmid:23773155
Li D et al. Efficacy and safety of probiotics in the treatment of Candida-associated stomatitis. 2014 Mycoses pmid:23952962
Kristanc L et al. The role of sterols in the lipid vesicle response induced by the pore-forming agent nystatin. 2014 Biochim. Biophys. Acta pmid:24863056
Serhan G et al. The polyene antifungals, amphotericin B and nystatin, cause cell death in Saccharomyces cerevisiae by a distinct mechanism to amphibian-derived antimicrobial peptides. 2014 Ann. Clin. Microbiol. Antimicrob. pmid:24884795
Mandigers PJ et al. The clinical significance of Cyniclomyces guttulatus in dogs with chronic diarrhoea, a survey and a prospective treatment study. 2014 Vet. Microbiol. pmid:24908274
Ruhil S et al. In vitro evaluation of combination of polyenes with EDTA against Aspergillus spp. by different methods (FICI and CI Model). 2014 J. Appl. Microbiol. pmid:24931000
Curvelo JA et al. Effect of the secretory leucocyte proteinase inhibitor (SLPI) on Candida albicans biological processes: a therapeutic alternative? 2014 Arch. Oral Biol. pmid:24907522
Hussein-Al-Ali SH et al. Antimicrobial and controlled release studies of a novel nystatin conjugated iron oxide nanocomposite. 2014 Biomed Res Int pmid:24900976
Rivarola de Gutierrez E et al. Topical treatment of oral lichen planus with anthocyanins. 2014 Med Oral Patol Oral Cir Bucal pmid:24880442
Lollis TR and Bradshaw WT Fungal prophylaxis in neonates: a review article. 2014 Adv Neonatal Care pmid:24472884
Ellepola AN and Samaranayake LP Impact of brief and sequential exposure to nystatin on the germ tube formation and cell surface hydrophobicity of oral Candida albicans isolates from human immunodeficiency virus-infected patients. 2014 Med Princ Pract pmid:24801278
Valitova J et al. Sterol binding by methyl-β-cyclodextrin and nystatin--comparative analysis of biochemical and physiological consequences for plants. 2014 FEBS J. pmid:24612537
Popa I et al. Expression and subcellular localization of RAGE in melanoma cells. 2014 Biochem. Cell Biol. pmid:24697697
Gitrowski C et al. Uptake of different crystal structures of TiOâ‚‚ nanoparticles by Caco-2 intestinal cells. 2014 Toxicol. Lett. pmid:24576787
Mansourian A et al. The comparative study of antifungal activity of Syzygium aromaticum, Punica granatum and nystatin on Candida albicans; an in vitro study. 2014 J Mycol Med pmid:25442923
Choukri F et al. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. 2014 J Mycol Med pmid:25442913
Piña-Vázquez C et al. Identification of phosphatidylcholine transfer protein-like in the parasite Entamoeba histolytica. 2014 Biochimie pmid:25223890
Boros-Majewska J et al. Novel Nystatin A₁ derivatives exhibiting low host cell toxicity and antifungal activity in an in vitro model of oral candidosis. 2014 Med. Microbiol. Immunol. pmid:24924305
Katyukhin LN A method for evaluation of membrane permeability for water by the erythrocyte osmotic deformability profiles. 2014 Bull. Exp. Biol. Med. pmid:24915951
Gerstein AC et al. Loss-of-heterozygosity facilitates passage through Haldane's sieve for Saccharomyces cerevisiae undergoing adaptation. 2014 Nat Commun pmid:24804896
Sheikh S et al. Fluorescence imaging of human cells with a novel conjugate of the antifungal nystatin. 2014 Med Chem pmid:24725140
Chukwuneke F et al. Concurrent Presentation of Burning Mouth Syndrome and Globus Pharyngis in Enugu, Nigeria: A Ten-year Clinical Evaluation. 2014 Oral Health Prev Dent pmid:24624402
Sklenár Z et al. Compounded preparations with nystatin for oral and oromucosal administration. 2013 Jul-Aug Acta Pol Pharm pmid:23923400
Giuliano S et al. Candidemia in Neurosurgical Intensive Care Unit: preliminary analysis of the effect of topical Nystatin prophylaxis and adequate source control on patients with early tracheostomy intubation. 2013 Jan-Feb Ann Ig pmid:23435780
Pinelli LA et al. Ricinus communis treatment of denture stomatitis in institutionalised elderly. 2013 J Oral Rehabil pmid:23438045
Siljamäki E et al. Cholesterol dependence of collagen and echovirus 1 trafficking along the novel α2β1 integrin internalization pathway. 2013 PLoS ONE pmid:23393580
Shi L et al. Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels. 2013 Nat Commun pmid:23385580
Wang W et al. The interaction of polysaccharide from Auricularia polytricha with quantum dots and the protection of plasmid DNA from damage. 2013 Appl. Biochem. Biotechnol. pmid:23440638
Tugizov SM et al. Epstein-Barr virus transcytosis through polarized oral epithelial cells. 2013 J. Virol. pmid:23698302
Ceccarelli G et al. Topical nystatin prophylaxis: a likely viable measure for reducing impact of candidemia in neurosurgical patients with early tracheostomy intubation. 2013 Crit Care pmid:23414732
Hothersall JD et al. Prolonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization. 2013 Br. J. Pharmacol. pmid:23581504
Bosanquet DC et al. Topical steroids for chronic wounds displaying abnormal inflammation. 2013 Ann R Coll Surg Engl pmid:23676816